Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.10x is 112% above its 3-year average of -9.33x, around the middle of its 3-year range (-34.58x–17.62x).
134.83% above its 12-month average of -3.16x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -6.93x.
INTEREST COVERAGE RATIO
1.10x
INTEREST COVERAGE RATIO AVG TTM
-3.16x
INTEREST COVERAGE RATIO AVG 3Y
-12.69x
INTEREST COVERAGE RATIO AVG 5Y
-9.33x
INTEREST COVERAGE RATIO AVG 10Y
-9.33x
INTEREST COVERAGE RATIO AVG 15Y
-9.33x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+134.83%
CURRENT VS 3Y AVG
+108.67%
CURRENT VS 5Y AVG
+111.79%
CURRENT VS 10Y AVG
+111.79%
CURRENT VS 15Y AVG
+111.79%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 331 covered companies
CURRENT VS SECTOR MEDIAN
+126.19%
vs the sector median at left
Arrowhead Pharmaceuticals, Inc.
Market Cap
$8.84B
Interest Coverage Ratio
1.10x
TTM Avg
-3.16x
3Y Avg
-12.69x
5Y Avg
-9.33x
Market Cap
$8.68B
Interest Coverage Ratio
0.79x
TTM Avg
0.79x
3Y Avg
0.79x
5Y Avg
1.52x
Market Cap
$9.04B
Interest Coverage Ratio
-1403.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.04B
Interest Coverage Ratio
-25.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.41B
Interest Coverage Ratio
-22.52x
TTM Avg
2.41x
3Y Avg
2.41x
5Y Avg
2.41x
Market Cap
$9.35B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$9.39B
Interest Coverage Ratio
5.94x
TTM Avg
6.59x
3Y Avg
5.07x
5Y Avg
3.90x
Market Cap
$9.60B
Interest Coverage Ratio
5.05x
TTM Avg
5.30x
3Y Avg
10.04x
5Y Avg
14.14x
Market Cap
$9.84B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $8.84B | 1.10x | -3.16x | -12.69x | -9.33x |
| Caris Life Sciences, Inc. (CAI)vs › | $8.68B | 0.79x | 0.79x | 0.79x | 1.52x |
| Kymera Therapeutics, Inc. (KYMR)vs › | $9.04B | -1403.21x | N/A | N/A | N/A |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.04B | -25.81x | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | -22.52x | 2.41x | 2.41x | 2.41x |
| Bruker Corporation (BRKRP)vs › | $9.35B | 3.91x | 4.60x | 15.68x | 18.14x |
| Insulet Corp. (PODD)vs › | $9.39B | 5.94x | 6.59x | 5.07x | 3.90x |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 5.05x | 5.30x | 10.04x | 14.14x |
| Bruker Corporation (BRKR)vs › | $9.84B | 3.91x | 4.60x | 15.68x | 18.14x |
| Krystal Biotech, Inc. (KRYS)vs › | $9.87B | N/A | N/A | N/A | N/A |
Interest Coverage
1.1x
Debt/Equity
1.86
Current Ratio
5.90
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -6.93x |
| 2026-03-31 | -5.92x |
| 2025-12-31 | 1.81x |
| 2025-09-30 | 2.03x |
| 2025-06-30 | -6.79x |
| 2025-03-31 | 17.62x |
| 2024-12-31 | -7.46x |
| 2024-09-30 | -11.07x |
| 2024-06-30 | -34.58x |
| 2024-03-31 | -17.42x |
| 2023-12-31 | -25.44x |
| 2023-09-30 | -20.59x |
| 2023-06-30 | -19.91x |
| 2023-03-31 | 9.52x |
| 2022-12-31 | -14.79x |
| 2013-09-30 | -271.09x |
| 2013-06-30 | -132.43x |
| 2013-03-31 | -195.53x |
| 2010-06-30 | -141.79x |
| 2010-03-31 | -186.89x |
| 2009-12-31 | -98.08x |
| 2009-09-30 | -171.26x |
| 2009-06-30 | -29.35x |
| 2009-03-31 | -79.45x |
